IMPROVEMENTS AND CORRELATIONS IN ORAL ULCERS, DISEASE ACTIVITY, AND QOL IN BEHCET'S SYNDROME PATIENTS TREATED WITH APREMILAST: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY